140 related articles for article (PubMed ID: 36896259)
1. Case report: Hilar metastasis of breast cancer: A single-center retrospective case-control study.
Yang R; Jia L; Lv Z; Cui J
Front Surg; 2023; 10():1025287. PubMed ID: 36896259
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
3. Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
Hong JC; Ayala-Peacock DN; Lee J; Blackstock AW; Okunieff P; Sung MW; Weichselbaum RR; Kao J; Urbanic JJ; Milano MT; Chmura SJ; Salama JK
PLoS One; 2018; 13(4):e0195149. PubMed ID: 29649281
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of clinical N0 metastatic non-small cell lung cancer.
Tamura T; Kurishima K; Watanabe H; Shiozawa T; Nakazawa K; Ishikawa H; Satoh H; Hizawa N
Lung Cancer; 2015 Jul; 89(1):71-5. PubMed ID: 25913230
[TBL] [Abstract][Full Text] [Related]
5. A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer.
Wang Z; Wang H; Ding X; Chen X; Shen K
Ther Adv Med Oncol; 2020; 12():1758835920932674. PubMed ID: 32550867
[TBL] [Abstract][Full Text] [Related]
6. Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
Soran A; Ozbas S; Ozcinar B; Isik A; Dogan L; Senol K; Dag A; Karanlik H; Aytac O; Karadeniz Cakmak G; Dalci K; Dogan M; Sezer YA; Gokgoz S; Ozyar E; Sezgin E;
Ann Surg Oncol; 2022 Oct; 29(10):6327-6336. PubMed ID: 35876920
[TBL] [Abstract][Full Text] [Related]
7. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes among HR+/HER2- metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US.
Xie J; Hao Y; Li N; Lin PL; Ohashi E; Koo V; Wu EQ
Exp Hematol Oncol; 2015; 4():31. PubMed ID: 26693096
[TBL] [Abstract][Full Text] [Related]
9. The results and prognosis of different treatment modalities for solitary metastatic lung tumor from nasopharyngeal carcinoma: a retrospective study of 105 cases.
Ma J; Wen ZS; Lin P; Wang X; Xie FY
Chin J Cancer; 2010 Sep; 29(9):787-95. PubMed ID: 20800020
[TBL] [Abstract][Full Text] [Related]
10. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
[TBL] [Abstract][Full Text] [Related]
11. Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma.
Winter H; Meimarakis G; Angele MK; Hummel M; Staehler M; Hoffmann RT; Hatz RA; Löhe F
J Urol; 2010 Nov; 184(5):1888-94. PubMed ID: 20846691
[TBL] [Abstract][Full Text] [Related]
12. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.
Planchard D; Soria JC; Michiels S; Grunenwald D; Validire P; Caliandro R; Girard P; Le Chevalier T
Cancer; 2004 Jan; 100(1):28-35. PubMed ID: 14692021
[TBL] [Abstract][Full Text] [Related]
13. Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer.
Yin Z; Tang H; Li L; Ni J; Yuan S; Lou H; Chen M
Cancer Manag Res; 2019; 11():7759-7766. PubMed ID: 31496818
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Bone Metastasis: A SEER-Based Study.
Xiaobin C; Zhaojun X; Tao L; Tianzeng D; Xuemei H; Fan Z; Chunyin H; Jianqiang H; Chen L
J Immunol Res; 2022; 2022():3251051. PubMed ID: 35211630
[TBL] [Abstract][Full Text] [Related]
15. Surgical approach to pulmonary metastases from breast cancer.
Kycler W; Laski P
Breast J; 2012; 18(1):52-7. PubMed ID: 22098366
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and survival analysis of 22 cases of pure epithelial breast metaplastic carcinoma].
Meng HM; Yang YF; Qi LQ; Gu L
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):525-9. PubMed ID: 24257306
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
[TBL] [Abstract][Full Text] [Related]
20. [Systematic mediastinal lymphadenectomy in surgery for sarcomatous pulmonary metastases].
Doležel J; Jedlička V; Capov I; Szkorupa M; Vodička J; Zvoniček V
Acta Chir Orthop Traumatol Cech; 2013; 80(1):77-81. PubMed ID: 23452426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
